Guidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus
dc.contributor.author | World Health Organization | en_US |
dc.coverage.spatial | Geneva | en_US |
dc.date.accessioned | 2018-04-30T14:26:17Z | |
dc.date.available | 2018-04-30T14:26:17Z | |
dc.date.issued | 2018 | |
dc.identifier.isbn | 9789241550284 | |
dc.identifier.uri | https://iris.who.int/handle/10665/272433 | |
dc.description | 68 p. | en_US |
dc.language.iso | en | en_US |
dc.publisher | World Health Organization | en_US |
dc.rights | CC BY-NC-SA 3.0 IGO | en_US |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-sa/3.0/igo | en_US |
dc.subject | WHO guideline | |
dc.subject.mesh | Diabetes Mellitus | en_US |
dc.subject.mesh | Blood Glucose | en_US |
dc.subject.mesh | Insulin | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Guideline | en_US |
dc.title | Guidelines on second- and third-line medicines and type of insulin for the control of blood glucose levels in non-pregnant adults with diabetes mellitus | en_US |
dc.type | Publications | en_US |
dc.subject.meshqualifier | drug therapy | en_US |
dc.rights.holder | World Health Organization | en_US |